Quantification of mRNA Decay Rates in HeLa and SH-SY5Y Cell Lines Reveals Novel Properties of Membrane Protein Coding...

Area of Science:

• Molecular Biology
• Genomics
• Pharmacology

Background:

• Posttranscriptional regulation significantly impacts small interfering RNA (siRNA) design and efficacy.
• Messenger RNA (mRNA) decay rates in cell lines are critical determinants of perceived siRNA potency.
• HeLa and SH-SY5Y cells are widely utilized in drug discovery research.

Purpose of the Study:

• To profile transcripts with varying half-lives in HeLa and SH-SY5Y cells.
• To correlate mRNA decay rates with siRNA activity and knockdown efficiency.
• To investigate features contributing to the stability of specific transcript types, such as those encoding membrane proteins.

Main Methods:

• Calculation of mRNA half-lives for 1,815 HeLa and 5,376 SH-SY5Y transcripts.
• Comparison of mRNA half-lives with corresponding protein half-lives.
• Integration of mRNA decay data with existing siRNA screening results from HeLa cells.
• Analysis of cis- and trans- acting features influencing mRNA stability and expression, including RNA binding protein (RBP) interactions.

Main Results:

• Comparable mRNA half-lives were observed between HeLa and SH-SY5Y cells, with HeLa generally exhibiting longer half-lives.
• Faster decaying transcripts encoded proteins with shorter half-lives, while slower decaying transcripts encoded stable proteins.
• Faster mRNA decay correlated with reduced siRNA knockdown efficiency.
• Transcripts encoding membrane proteins were surprisingly stable and amenable to knockdown, despite low-to-moderate expression levels.
• Low RNA binding protein (RBP) binding and specific stabilizing RBP regulation were implicated in the stability of membrane protein-coding transcripts.

Conclusions:

• mRNA decay rates are a critical factor influencing siRNA efficacy, particularly for transcripts encoding membrane proteins.
• Understanding transcript stability and decay mechanisms is essential for optimizing siRNA design in drug discovery.
• Specific regulatory mechanisms involving RBPs contribute to the stability of certain transcript classes, impacting their response to siRNA-mediated knockdown.